申请人:Ali Amjad
公开号:US20100273845A1
公开(公告)日:2010-10-28
A compound having the structure
wherein R is an angiotensin receptor antagonist active group, and Y is
1) —(CH
2
)
3
R
5
,
2) —C(O)(CH
2
)
2
R
5
,
3) —C(R
1
R
2
)OC(O)O(CH
2
)
n
R
5
, wherein n is 1 or 2,
4) —C(R
1
R
2
)OC(O)CH
2
CH
2
R
5
,
5) —C(R
1
R
2
)OC(O)OCH
2
CH
2
C(R
3
R
4
)R
5
,
provided that when Y is —C(O)(CH
2
)
2
R
5
, then R is
R
1
, R
2
, R
3
and R
4
are independently selected from the group consisting of hydrogen and C
1-4
alkyl;
R
5
is —CH(ONO
2
)CH(ONO
2
)R
6
;
R
6
is selected from CH
3
, CH
2
CH
3
and CH(CH
3
)
2
;
or a pharmaceutically acceptable salt or hydrate thereof, which is useful for treating hypertension.
一种具有以下结构的化合物,其中R为血管紧张素受体拮抗剂活性基团,Y为1)—(CH2)3R5,2)—C(O)(CH2)2R5,3)—C(R1R2)OC(O)O(CH2)nR5,其中n为1或2,4)—C(R1R2)OC(O)CH2CH2R5,5)—C(R1R2)OC(O)OCH2CH2C(R3R4)R5,前提是当Y为—C(O)(CH2)2R5时,R为R1,R2,R3和R4中的任意一种,其选择自氢和C1-4烷基的群;R5为—CH(ONO2)CH(ONO2)R6;R6选择自CH3,CH2CH3和CH(CH3)2;或其药学上可接受的盐或水合物,用于治疗高血压。